2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | PHARMACEUTICAL BIOLOGY PHARM BIOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.8
59人评分
我要评分
声誉 6.5 影响力 4.8 速度 8.3 | |||||||||||||||||||||||||||||||||
期刊ISSN | 1388-0209 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||||
E-ISSN | 1744-5116 | |||||||||||||||||||||||||||||||||
2022-2023最新影响因子 (数据来源于搜索引擎) | 3.8 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||
实时影响因子 | 截止2023年12月27日:3.308 | |||||||||||||||||||||||||||||||||
2022-2023自引率 | 2.60%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
五年影响因子 | 4.4 | |||||||||||||||||||||||||||||||||
h-index | 53 | |||||||||||||||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||||
期刊官方网站 | http://informahealthcare.com/page/Description?journalCode=phb#Instructions&cookieSet=1 | |||||||||||||||||||||||||||||||||
期刊投稿网址 | http://mc.manuscriptcentral.com/nphb | |||||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足PHARMACEUTICAL BIOLOGY的语言要求,还能让PHARMACEUTICAL BIOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被PHARMACEUTICAL BIOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD1950; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:biologically-active chemicals、pharmaceutical products、pharmaceutical biology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardDouble blind peer review | |||||||||||||||||||||||||||||||||
通讯方式 | TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106 | |||||||||||||||||||||||||||||||||
出版商 | Taylor and Francis Ltd. | |||||||||||||||||||||||||||||||||
涉及的研究方向 | 医学-药学 | |||||||||||||||||||||||||||||||||
出版国家或地区 | NETHERLANDS | |||||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||||
出版周期 | Bimonthly | |||||||||||||||||||||||||||||||||
出版年份 | 1998 | |||||||||||||||||||||||||||||||||
年文章数 | 215点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
Gold OA文章占比 | 95.64% | |||||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 93.95% | |||||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2022-2023年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||||
中科院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1388-0209%5BISSN%5D | |||||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均1.0个月 | |||||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 约62.5% | |||||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在PHARMACEUTICAL BIOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Assessments of CYP-inhibition-based drug-drug interaction between vonoprazan and poziotinib in vitro and in vivo Author: Zhou, Shan; Zhao, Fang-Ling; Wang, Shuang-Hu; Wang, Yi-Ran; Hong, Yun; Zhou, Quan; Geng, Pei-Wu; Luo, Qing-Feng; Cai, Jian-Ping; Dai, Da-Peng Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 356-361. DOI: 10.1080/13880209.2023.2173253 PubMed DOI |
2. | Protective effect of Qingluotongbi formula against Tripterygium wilfordii induced liver injury in mice by improving fatty acid beta-oxidation and mitochondrial biosynthesis Author: Zhou, Jie; Li, Ming; Yu, Zhichao; Li, Changqing; Zhou, Lingling; Zhou, Xueping Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 80-88. DOI: 10.1080/13880209.2022.2157842 PubMed DOI |
3. | Gualou Guizhi decoction promotes therapeutic angiogenesis via the miR210/HIF/VEGF pathway in vivo and in vitro Author: Zhang, Yuqin; Cao, Yajun; Li, Yan; Xiao, Lijuan; Xu, Wei; Xu, Wen; Huang, Mei; Zhang, Xiaoqin; Chen, Yaping; Nan, Lihong Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 779-789. DOI: 10.1080/13880209.2023.2204142 PubMed DOI |
4. | Chinese herbal compound Huangqin Qingrechubi capsule reduces lipid metabolism disorder and inflammatory response in gouty arthritis via the LncRNA H19/APN/PI3K/AKT cascade Author: Zhang, Xianheng; Liu, Jian; Sun, Yanqiu; Zhou, Qin; Ding, Xiang; Chen, Xiaolu Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 541-555. DOI: 10.1080/13880209.2023.2191641 PubMed DOI |
5. | Daphnetin alleviates neuropathic pain in chronic constrictive injury rats via regulating the NF-kappa B dependent CXCL1/CXCR2 signaling pathway Author: Zhang, Tianrui; Liang, Wulin; Ou, Wenjing; Zhang, Mingqian; Cui, Shuang; Zhang, Shuofeng Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 746-754. DOI: 10.1080/13880209.2023.2198560 PubMed DOI |
6. | Kazinol B protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced cardiac injury by modulating the AKT/AMPK/Nrf2 signalling pathway Author: Zhang, Qian; Dang, Yuan-Ye; Luo, Xiu; Fu, Ji-Jun; Zou, Zhi-Cong; Jia, Xue-Jing; Zheng, Guo-Dong; Li, Chu-Wen Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 362-371. DOI: 10.1080/13880209.2023.2173247 PubMed DOI |
7. | Stigmasterol alleviates allergic airway inflammation and airway hyperresponsiveness in asthma mice through inhibiting substance-P receptor Author: Zhang, Jimei; Zhang, Chonghong; Miao, Li; Meng, Zimin; Gu, Ning; Song, Guifang Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 449-458. DOI: 10.1080/13880209.2023.2173252 PubMed DOI |
8. | Panax ginseng improves physical recovery and energy utilization on chronic fatigue in rats through the PI3K/AKT/mTOR signalling pathway Author: Zhang, Guolei; Lu, BoFan; Wang, Enhui; Wang, Wei; Li, Zheng; Jiao, Lili; Li, Hui; Wu, Wei Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 316-323. DOI: 10.1080/13880209.2023.2169719 PubMed DOI |
9. | Repair mechanism of Yishen Tongluo formula on mouse sperm DNA fragmentation caused by polystyrene microplastics Author: Zhang, Chenming; Wang, Zulong; Ma, Sicheng; Chen, Rubing; Wang, Shiqi; Zhang, Hao; Hua, Zhong; Sun, Zixue Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 488-498. DOI: 10.1080/13880209.2023.2168705 PubMed DOI |
10. | Baicalein attenuates bleomycin-induced lung fibroblast senescence and lung fibrosis through restoration of Sirt3 expression Author: Yuan, Ji-hong; Ma, Yu; Yuan, Ling-hong; Gong, Jing-jing; Xu, Ling-li; Wang, Lv; Jin, Yong-mei Journal: PHARMACEUTICAL BIOLOGY. 2023; Vol. 61, Issue 1, pp. 288-297. DOI: 10.1080/13880209.2022.2160767 PubMed DOI |
|
|
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共323条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451